Literature DB >> 22555633

Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome.

Jill A Parnell1, Raylene A Reimer.   

Abstract

Prebiotic fibers are non-digestible carbohydrates that promote the growth of beneficial bacteria in the gut. Prebiotic consumption may benefit obesity and associated co-morbidities by improving or normalizing the dysbiosis of the gut microbiota. We evaluated the dose response to a prebiotic diet on the gut microbiota, body composition and obesity associated risk factors in lean and genetically obese rats. Prebiotic fibers increased Firmicutes and decreased Bacteroidetes, a profile often associated with a leaner phenotype. Bifidobacteria and Lactobacillus numbers also increased. Changes in the gut microbiota correlated with energy intake, glucose, insulin, satiety hormones, and hepatic cholesterol and triglyceride accumulation. Here we provide a comprehensive analysis evaluating the results through the lens of the gut microbiota. Salient, new developments impacting the interpretation and significance of our data are discussed. We propose that prebiotic fibers have promise as a safe and cost-effective means of modulating the gut microbiota to promote improved host:bacterial interactions in obesity and insulin resistance. Human clinical trials should be undertaken to confirm these effects.

Entities:  

Mesh:

Year:  2012        PMID: 22555633      PMCID: PMC3827018          DOI: 10.4161/gmic.19246

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  61 in total

Review 1.  Prebiotics and probiotics: are they functional foods?

Authors:  M B Roberfroid
Journal:  Am J Clin Nutr       Date:  2000-06       Impact factor: 7.045

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

3.  Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.

Authors:  Y Kadooka; M Sato; K Imaizumi; A Ogawa; K Ikuyama; Y Akai; M Okano; M Kagoshima; T Tsuchida
Journal:  Eur J Clin Nutr       Date:  2010-03-10       Impact factor: 4.016

4.  Effect of prebiotic fibre supplementation on hepatic gene expression and serum lipids: a dose-response study in JCR:LA-cp rats.

Authors:  Jill A Parnell; Raylene A Reimer
Journal:  Br J Nutr       Date:  2009-12-21       Impact factor: 3.718

Review 5.  Targeting gut microbiota in obesity: effects of prebiotics and probiotics.

Authors:  Nathalie M Delzenne; Audrey M Neyrinck; Fredrik Bäckhed; Patrice D Cani
Journal:  Nat Rev Endocrinol       Date:  2011-08-09       Impact factor: 43.330

6.  Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women.

Authors:  A Santacruz; M C Collado; L García-Valdés; M T Segura; J A Martín-Lagos; T Anjos; M Martí-Romero; R M Lopez; J Florido; C Campoy; Y Sanz
Journal:  Br J Nutr       Date:  2010-03-08       Impact factor: 3.718

7.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

8.  High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

Authors:  Jean-Marc Sabaté; Pauline Jouët; Florence Harnois; Charlotte Mechler; Simon Msika; Maggy Grossin; Benoît Coffin
Journal:  Obes Surg       Date:  2008-02-20       Impact factor: 4.129

9.  High-fat diet determines the composition of the murine gut microbiome independently of obesity.

Authors:  Marie A Hildebrandt; Christian Hoffmann; Scott A Sherrill-Mix; Sue A Keilbaugh; Micah Hamady; Ying-Yu Chen; Rob Knight; Rexford S Ahima; Frederic Bushman; Gary D Wu
Journal:  Gastroenterology       Date:  2009-08-23       Impact factor: 22.682

10.  Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.

Authors:  K Zwirska-Korczala; S J Konturek; M Sodowski; M Wylezol; D Kuka; P Sowa; M Adamczyk-Sowa; M Kukla; A Berdowska; J F Rehfeld; W Bielanski; T Brzozowski
Journal:  J Physiol Pharmacol       Date:  2007-03       Impact factor: 3.011

View more
  45 in total

1.  Commercial rodent diets differentially regulate autoimmune glomerulonephritis, epigenetics and microbiota in MRL/lpr mice.

Authors:  Michael R Edwards; Rujuan Dai; Bettina Heid; Thomas E Cecere; Deena Khan; Qinghui Mu; Catharine Cowan; Xin M Luo; S Ansar Ahmed
Journal:  Int Immunol       Date:  2017-06-01       Impact factor: 4.823

Review 2.  Seaweeds as potential therapeutic interventions for the metabolic syndrome.

Authors:  Senthil Arun Kumar; Lindsay Brown
Journal:  Rev Endocr Metab Disord       Date:  2013-09       Impact factor: 6.514

3.  Regulation of thermogenic capacity in brown and white adipocytes by the prebiotic high-esterified pectin and its postbiotic acetate.

Authors:  Francisco García-Carrizo; Barbara Cannon; Jan Nedergaard; Catalina Picó; Albert Dols; Ana María Rodríguez; Andreu Palou
Journal:  Int J Obes (Lond)       Date:  2019-08-29       Impact factor: 5.095

Review 4.  Microbiota and nonalcoholic steatohepatitis.

Authors:  Kento Imajo; Masato Yoneda; Yuji Ogawa; Koichiro Wada; Atsushi Nakajima
Journal:  Semin Immunopathol       Date:  2013-12-14       Impact factor: 9.623

Review 5.  Epigenetic effects of the pregnancy Mediterranean diet adherence on the offspring metabolic syndrome markers.

Authors:  David Lorite Mingot; Eva Gesteiro; Sara Bastida; Francisco J Sánchez-Muniz
Journal:  J Physiol Biochem       Date:  2017-09-18       Impact factor: 4.158

6.  Resistant maltodextrin or fructooligosaccharides promotes GLP-1 production in male rats fed a high-fat and high-sucrose diet, and partially reduces energy intake and adiposity.

Authors:  Tohru Hira; Ryoya Suto; Yuka Kishimoto; Sumiko Kanahori; Hiroshi Hara
Journal:  Eur J Nutr       Date:  2017-02-04       Impact factor: 5.614

Review 7.  Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease.

Authors:  Pietro Vajro; Giulia Paolella; Alessio Fasano
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-05       Impact factor: 2.839

8.  Allobaculum Involves in the Modulation of Intestinal ANGPTLT4 Expression in Mice Treated by High-Fat Diet.

Authors:  Zibin Zheng; Wentao Lyu; Ying Ren; Xiaoqiong Li; Shenjun Zhao; Hua Yang; Yingping Xiao
Journal:  Front Nutr       Date:  2021-05-19

Review 9.  Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions.

Authors:  Pietro Vajro; Selvaggia Lenta; Claudio Pignata; Mariacarolina Salerno; Roberta D'Aniello; Ida De Micco; Giulia Paolella; Giancarlo Parenti
Journal:  Ital J Pediatr       Date:  2012-10-17       Impact factor: 2.638

Review 10.  Influence of gut microbiota on subclinical inflammation and insulin resistance.

Authors:  Bruno Melo Carvalho; Mario Jose Abdalla Saad
Journal:  Mediators Inflamm       Date:  2013-06-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.